Northwestern Mutual Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59.3M Buy
272,530
+1,957
+0.7% +$434K 0.04% 246
2025
Q4
$61.8M Buy
270,573
+7,665
+3% +$1.75M 0.04% 233
2025
Q3
$60.9M Buy
262,908
+1,872
+0.7% +$381K 0.04% 222
2025
Q2
$48.5M Buy
261,036
+11,322
+5% +$2.1M 0.04% 254
2025
Q1
$52.3M Buy
249,714
+755
+0.3% +$147K 0.04% 201
2024
Q4
$44.2M Buy
248,959
+7,293
+3% +$1.34M 0.04% 226
2024
Q3
$47.7M Buy
241,666
+14,595
+6% +$2.72M 0.04% 211
2024
Q2
$38.9M Buy
227,071
+1,843
+0.8% +$305K 0.04% 234
2024
Q1
$41M Buy
225,228
+27,453
+14% +$4.73M 0.04% 223
2023
Q4
$30.6M Sell
197,775
-13,029
-6% -$1.9M 0.03% 243
2023
Q3
$31.4M Buy
210,804
+2,410
+1% +$354K 0.04% 219
2023
Q2
$28.1M Sell
208,394
-8,927
-4% -$1.31M 0.04% 237
2023
Q1
$34.6M Buy
217,321
+12,093
+6% +$1.85M 0.05% 191
2022
Q4
$33.2M Buy
205,228
+17,307
+9% +$2.65M 0.05% 188
2022
Q3
$25.2M Sell
187,921
-7,305
-4% -$1.05M 0.04% 198
2022
Q2
$29.9M Buy
195,226
+6,683
+4% +$1.02M 0.05% 171
2022
Q1
$30.6M Buy
188,543
+7,951
+4% +$1.15M 0.05% 181
2021
Q4
$24.5M Buy
180,592
+12,008
+7% +$1.42M 0.04% 187
2021
Q3
$18.2M Sell
168,584
-37,658
-18% -$4.3M 0.03% 200
2021
Q2
$23.2M Sell
206,242
-2,029
-1% -$229K 0.04% 172
2021
Q1
$22.5M Buy
208,271
+14,754
+8% +$1.58M 0.05% 161
2020
Q4
$20.7M Buy
193,517
+50,320
+35% +$4.84M 0.05% 157
2020
Q3
$12.5M Sell
143,197
-685
-0.5% -$64.5K 0.03% 190
2020
Q2
$14.1M Buy
143,882
+10,198
+8% +$898K 0.04% 171
2020
Q1
$10.2M Buy
133,684
+9,844
+8% +$838K 0.04% 178
2019
Q4
$11M Buy
123,840
+2,189
+2% +$182K 0.04% 180
2019
Q3
$9.21M Buy
121,651
+2,669
+2% +$183K 0.04% 195
2019
Q2
$8.65M Sell
118,982
-27
-0% -$2.12K 0.03% 197
2019
Q1
$9.59M Sell
119,009
-3,650
-3% -$299K 0.04% 176
2018
Q4
$11.3M Buy
122,659
+1,749
+1% +$154K 0.06% 156
2018
Q3
$11.4M Sell
120,910
-16,628
-12% -$1.58M 0.06% 156
2018
Q2
$12.7M Buy
137,538
+4,186
+3% +$409K 0.07% 133
2018
Q1
$12.6M Buy
133,352
+19,050
+17% +$2.09M 0.08% 134
2017
Q4
$11.1M Sell
114,302
-1,154
-1% -$109K 0.07% 141
2017
Q3
$10.3M Buy
115,456
+6,859
+6% +$522K 0.07% 144
2017
Q2
$7.87M Buy
108,597
+2,312
+2% +$155K 0.06% 151
2017
Q1
$6.93M Buy
106,285
+7
+0% +$440 0.06% 152
2016
Q4
$6.66M Buy
106,278
+92,300
+660% +$5.63M 0.07% 149
2016
Q3
$882K Sell
13,978
-85,864
-86% -$5.56M 0.06% 111
2016
Q2
$6.18M Buy
99,842
+1,507
+2% +$91.8K 0.09% 147
2016
Q1
$5.62M Buy
98,335
+12,358
+14% +$689K 0.09% 147
2015
Q4
$5.09M Buy
85,977
+2,124
+3% +$122K 0.1% 152
2015
Q3
$4.56M Buy
83,853
+5,496
+7% +$358K 0.11% 147
2015
Q2
$5.26M Buy
78,357
+389
+0.5% +$25.4K 0.14% 127
2015
Q1
$4.56M Sell
77,968
-2,449
-3% -$148K 0.13% 140
2014
Q4
$5.26M Buy
80,417
+2,917
+4% +$184K 0.16% 121
2014
Q3
$4.48M Buy
77,500
+12,499
+19% +$694K 0.16% 119
2014
Q2
$3.67M Sell
65,001
-385
-0.6% -$20.2K 0.14% 124
2014
Q1
$3.36M Sell
65,386
-2,717
-4% -$137K 0.14% 122
2013
Q4
$3.6M Sell
68,103
-3,416
-5% -$168K 0.16% 111
2013
Q3
$3.2M Sell
71,519
-809
-1% -$35.9K 0.17% 117
2013
Q2
$2.99M Buy
+72,328
New +$3.16M 0.18% 111

Other funds holding ABBV

Northwestern Mutual Wealth Management's ABBV Position: Q1 2026 in Review

Northwestern Mutual Wealth Management increased its AbbVie (ABBV) stake by 0.72% in Q1 2026, buying an estimated $434K and bringing the position to 272,530 shares worth $59.3M. The position accounts for 0.04% of the portfolio, ranked #246.

Northwestern Mutual Wealth Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $61.8M in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Northwestern Mutual Wealth Management held 272,530 shares of AbbVie worth $59.3M as of Q1 2026.
  • Northwestern Mutual Wealth Management bought 1,957 AbbVie shares in Q1 2026, an estimated $434K.
  • AbbVie made up 0.04% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #246 holding.
  • Northwestern Mutual Wealth Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Northwestern Mutual Wealth Management's AbbVie position peaked at $61.8M in Q4 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.